Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Connect Biopharma Holdings (CNTB) Net Margin (2024 - 2025)

Historic Net Margin for Connect Biopharma Holdings (CNTB) over the last 2 years, with Q3 2025 value amounting to 107500.0%.

  • Connect Biopharma Holdings' Net Margin fell 1064437200.0% to 107500.0% in Q3 2025 from the same period last year, while for Sep 2025 it was 6466.8%, marking a year-over-year decrease of 59153600.0%. This contributed to the annual value of 60.03% for FY2024, which is N/A changed from last year.
  • Latest data reveals that Connect Biopharma Holdings reported Net Margin of 107500.0% as of Q3 2025, which was down 1064437200.0% from 26872.92% recorded in Q2 2025.
  • In the past 5 years, Connect Biopharma Holdings' Net Margin ranged from a high of 1056.28% in Q3 2024 and a low of 107500.0% during Q3 2025